Rachael Fleurence, PhD, Joins MDIC as Executive Director, Coordinating Center

Life Science Partner recruited Rachael Fleurence, PhD, to serve as the MDIC’s Executive Director, Coordinating Center in partnership with the National Evaluation System for Health Technology (NEST).

MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science. MDIC is a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment. The U.S. Food and Drug Administration (FDA) has awarded the MDIC $3 million in seed funding to establish the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST).

While at PCORI, Fleurence lead the launch of PCORnet, a national patient centered research network consisting of 130 institutions and patient groups nationwide. She also directed the Clinical Research Methods program in areas including comparative effectiveness research, methods for patient engagement and research prioritization and analytical methodologies.

“The initial phase of the NEST project will include demonstration projects piloting methods for tracking medical device data and patient-reported outcomes through the use of real-world evidence., Fleurence has the unique capability to lead the vision and execution of the MDIC’s Coordinating Center in partnership with NEST,” states Tom Callaway, MD, Founder of Life Science Partner.

Rachael Fleurence earned her Bachelor of Arts Degree in Social and Political Science from University of Cambridge, UK, and her MA in business management from ESSEC- Paris. She completed her Master of Science and PhD in health economics from the University of York. She also completed her AMIA 10X10 Bioinformatics Certificate from the Oregon Health and Sciences University.

Chris Stein, MD, PhD, Joins Allergan As Director, Medical Safety Physician

Former Global Pharmacovigilance and Clinical Safety Physician Otsuka Pharmaceuticals

Chris Stein, MD, PhD, was recruited by Life Science Partner to serve as Director, Medical Safety Physician for Allergan where he will oversee Pharmacovigilance for Allergan’s CNS drug portfolio.

In his previous role at Otsuka, Stein partnered with safety physicians at Bristol Myers Squibb to co-market the block buster drug, Abilify, and formulate a regulatory compliance strategy and risk management plan while providing signal evaluation and drug safety reporting.

“Intelligent, articulate and passionate about pharmacovigilance, Stein will be able to hit the ground running in his CNS role for Allergan’s pharmacovigilance team,” states Tom Callaway, MD, Founder and President of Life Science Partner. “He brings exceptional analytical and writing skills to be a great addition to the team.”

Chris Stein earned his Bachelor of Science Degree in Biology and Computer Science in 1984 from the Southwest Missouri State University. He completed his MD and PhD from the St. Louis University School of Medicine and his MPH from the University of Kentucky College of Public Health.

Tony Brennan Joins UL as Director, North American Sales

Former Director, Business Development at Erdman

Tony Brennan has joined Underwriters Laboratories as Director, North American Sales for the company’s Health Sciences business unit reporting to Upayan SenGupta, Vice President, General Manager, Health Sciences—SenGupta was recruited to UL by Life Science Partner in 2015. Brennan previously served as Director, Business Development for Erdman, a consulting firm dedicated to providing integrated solutions for healthcare clients.

Brennan’s career has been focused on building and leading strategic healthcare sales teams and cultivating key relationships with Group Purchasing Organizations and Integrated Delivery Networks. He has previously held sales leadership roles at HeartSine Technologies, Angelica, Cardionow, Cordis and GE Healthcare.

In his role at UL, Brennan will oversee the sales and new business development for the company’s rapidly growing Health Sciences Division. Brennan will be lead the transformation of the business from selling traditional compliance and audit services to becoming a proactive partner in the registration and product development teams for UL’s clients.

Brennan earned his Bachelor of Science in Biology and Chemistry from Bowling Green State University.